Neurofilament protein in cerebrospinal fluid:: A marker of white matter changes

被引:156
作者
Sjögren, M
Blomberg, M
Jonsson, M
Wahlund, LO
Edman, Å
Lind, K
Rosengren, L
Blennow, K
Wallin, A
机构
[1] Res Council, Stockholm, Sweden
[2] Huddinge Univ Hosp, Neurotec Inst, Dept Geriatr Med, S-14186 Huddinge, Sweden
[3] Univ Gothenburg, Inst Clin Neurosci, Gothenburg, Sweden
关键词
white matter; dementia; axonal degeneration;
D O I
10.1002/jnr.1242
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The objective of this study was to compare cerebrospinal fluid (CSF) levels of the light subtype of the neurofilament proteins (NFL), tau, and beta -amyioid42 (A beta 42) in individuals with moderate or severe white matter changes (WMC) and in those with mild or no WMC. Twenty-two patients with Alzheimer's disease (AD), nine patients with subcortical vascular dementia (SVD), and 20 normal controls were included in the study. The occurrence of WMC was evaluated by a neuroradiologist using the Blennow-Wallin scale. Thirty-seven subjects had no or only punctate WMC 14 had moderate to severe WMC. Both diagnostic group and WMC, but not gender or apolipoproteinE E4 inheritance, contributed to the variance in the CSF levels of tau, NFL, and A beta 42. In patients with moderate to severe WMC, CSF NFL (P < 0.01), but not CSF tau or CSF A beta 42, was increased also after correction for age, gender, and degree of cognitive impairment. A comparison between patients and controls with any signs of WIVIC and those without such signs yielded a similar result: CSF NFL (P < 0.001) was increased in the group with signs of WMC. As in numerous previous studies, we found that CSF tau was increased in AD (P < 0.001) compared with controls. Furthermore, CSF NFL was increased in both AD and SVD compared with controls (P < 0.001 for both). Although diagnostic group seems to be a stronger predictor of the variance found in CSF NFL, a clear association between the presence of WIVIC and increased CSF NFL was found. Because NFL is located mainly in large myelinated axons, increased CSF NFL in individuals with WMC probably reflects axonal degeneration. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:510 / 516
页数:7
相关论文
共 59 条
  • [1] Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study
    Andreasen, N
    Vanmechelen, E
    Van de Voorde, A
    Davidsson, P
    Hesse, C
    Tarvonen, S
    Räihä, I
    Sourander, L
    Winblad, B
    Blennow, K
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) : 298 - 305
  • [2] Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease -: Differences between early- and late-onset Alzheimer disease and stability during the course of disease
    Andreasen, N
    Hesse, C
    Davidsson, P
    Minthon, L
    Wallin, A
    Winblad, B
    Vanderstichele, H
    Vanmechelen, E
    Blennow, K
    [J]. ARCHIVES OF NEUROLOGY, 1999, 56 (06) : 673 - 680
  • [3] [Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
  • [4] Arai H, 1997, GERONTOLOGY, V43, P2
  • [5] Biological markers for the clinical diagnosis of Alzheimer's disease
    Arai, H
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 179 (02) : 65 - 79
  • [6] BLENNOW K, 1990, ACTA NEUROL SCAND, V81, P323
  • [7] PROTEIN ANALYSES IN CEREBROSPINAL-FLUID .1. INFLUENCE OF CONCENTRATION GRADIENTS FOR PROTEINS ON CEREBROSPINAL-FLUID SERUM-ALBUMIN RATIO
    BLENNOW, K
    FREDMAN, P
    WALLIN, A
    GOTTFRIES, CG
    LANGSTROM, G
    SVENNERHOLM, L
    [J]. EUROPEAN NEUROLOGY, 1993, 33 (02) : 126 - 128
  • [8] tau protein in cerebrospinal fluid - A biochemical marker for axonal degeneration in Alzheimer disease?
    Blennow, K
    Wallin, A
    Agren, H
    Spenger, C
    Siegfried, J
    Vanmechelen, E
    [J]. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 26 (03) : 231 - 245
  • [9] WHITE-MATTER LESIONS ON CT IN ALZHEIMER PATIENTS - RELATION TO CLINICAL SYMPTOMATOLOGY AND VASCULAR FACTORS
    BLENNOW, K
    WALLIN, A
    UHLEMANN, C
    GOTTFRIES, CG
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1991, 83 (03): : 187 - 193
  • [10] BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416